Daily Archives: May 20, 2016

2015 James W. Freston Single Topic Conference: A Renaissance in the Understanding and Management of Irritable Bowel Syndrome

Posted on May 20, 2016 by Lin Chang, Margaret M. Heitkemper, John W. Wiley, Michael Camilleri

In honor of one of its past presidents, the American Gastroenterological Association (AGA) started the James W. Freston Single Topic Conference, which has been held annually since 2009. The 2015 Freston conference included state-of-the art lectures and… Continue reading →

Posted in News | Comments Off on 2015 James W. Freston Single Topic Conference: A Renaissance in the Understanding and Management of Irritable Bowel Syndrome

2015 James W. Freston Single Topic Conference: A Renaissance in the Understanding and Management of Irritable Bowel Syndrome

Posted on May 20, 2016 by Lin Chang, Margaret M. Heitkemper, John W. Wiley, Michael Camilleri

In honor of one of its past presidents, the American Gastroenterological Association (AGA) started the James W. Freston Single Topic Conference, which has been held annually since 2009. The 2015 Freston conference included state-of-the art lectures and… Continue reading →

Posted in News | Comments Off on 2015 James W. Freston Single Topic Conference: A Renaissance in the Understanding and Management of Irritable Bowel Syndrome

Rectal Indomethacin Reduces Pancreatitis in High- and Low-Risk Patients Undergoing Endoscopic Retrograde Cholangiopancreatography

Posted on May 20, 2016 by Nikhil R. Thiruvengadam, Kimberly A. Forde, Gene K. Ma, Nuzhat Ahmad, Vinay Chandrasekhara, Gregory G. Ginsberg, Immanuel K. Ho, David Jaffe, Kashyap V. Panganamamula, Michael L. Kochman

Rectal indomethacin reduces the risk of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP). Most studies of its efficacy included high-risk cohorts and excluded low-risk patients, including those with malignant biliary obstructio… Continue reading →

Posted in News | Comments Off on Rectal Indomethacin Reduces Pancreatitis in High- and Low-Risk Patients Undergoing Endoscopic Retrograde Cholangiopancreatography

Rectal Indomethacin Reduces Pancreatitis in High- and Low-Risk Patients Undergoing Endoscopic Retrograde Cholangiopancreatography

Posted on May 20, 2016 by Nikhil R. Thiruvengadam, Kimberly A. Forde, Gene K. Ma, Nuzhat Ahmad, Vinay Chandrasekhara, Gregory G. Ginsberg, Immanuel K. Ho, David Jaffe, Kashyap V. Panganamamula, Michael L. Kochman

Rectal indomethacin reduces the risk of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP). Most studies of its efficacy included high-risk cohorts and excluded low-risk patients, including those with malignant biliary obstructio… Continue reading →

Posted in News | Comments Off on Rectal Indomethacin Reduces Pancreatitis in High- and Low-Risk Patients Undergoing Endoscopic Retrograde Cholangiopancreatography

First Do No Harm: Is It Safe to Use Immunosuppressants in Inflammatory Bowel Disease Patients With Prior Cancer?

Posted on May 20, 2016 by Geoffrey C. Nguyen

As the inflammatory bowel disease (IBD) population ages and the incidence of elderly-onset IBD increases, the prevalence of elderly IBD will continue to increase.1 In North America, the increase in prevalence of IBD was higher in the elderly population… Continue reading →

Posted in News | Comments Off on First Do No Harm: Is It Safe to Use Immunosuppressants in Inflammatory Bowel Disease Patients With Prior Cancer?

First Do No Harm: Is It Safe to Use Immunosuppressants in Inflammatory Bowel Disease Patients With Prior Cancer?

Posted on May 20, 2016 by Geoffrey C. Nguyen

As the inflammatory bowel disease (IBD) population ages and the incidence of elderly-onset IBD increases, the prevalence of elderly IBD will continue to increase.1 In North America, the increase in prevalence of IBD was higher in the elderly population… Continue reading →

Posted in News | Comments Off on First Do No Harm: Is It Safe to Use Immunosuppressants in Inflammatory Bowel Disease Patients With Prior Cancer?

Good News–Bad News: Current Status of GI Cancers

Posted on May 20, 2016 by Gregory J. Gores, David Lieberman

The annual report on cancer (of all types) in the United States is a collaborative effort from the American Cancer Society, Centers for Disease Control and Prevention, the National Cancer Institute, and the North American Associate of Central Cancer Re… Continue reading →

Posted in News | Comments Off on Good News–Bad News: Current Status of GI Cancers

Good News–Bad News: Current Status of GI Cancers

Posted on May 20, 2016 by Gregory J. Gores, David Lieberman

The annual report on cancer (of all types) in the United States is a collaborative effort from the American Cancer Society, Centers for Disease Control and Prevention, the National Cancer Institute, and the North American Associate of Central Cancer Re… Continue reading →

Posted in News | Comments Off on Good News–Bad News: Current Status of GI Cancers

Toward a Better Drug for Gastroparesis: The Problem With a Moving Target

Posted on May 20, 2016 by Pankaj Jay Pasricha, William Snape

Gastroparesis, a disorder defined by delayed gastric emptying, and characterized by nausea, vomiting, and other chronic debilitating symptoms that improves little over time, remains among the most challenging gastroenterological conditions to treat.1 W… Continue reading →

Posted in News | Comments Off on Toward a Better Drug for Gastroparesis: The Problem With a Moving Target

Toward a Better Drug for Gastroparesis: The Problem With a Moving Target

Posted on May 20, 2016 by Pankaj Jay Pasricha, William Snape

Gastroparesis, a disorder defined by delayed gastric emptying, and characterized by nausea, vomiting, and other chronic debilitating symptoms that improves little over time, remains among the most challenging gastroenterological conditions to treat.1 W… Continue reading →

Posted in News | Comments Off on Toward a Better Drug for Gastroparesis: The Problem With a Moving Target